Effect of Modifide Wenjingtang on JAK2/STAT3 Signal Pathway and Downstream Factors Protein Expression in Endometriosis Rats
10.13422/j.cnki.syfjx.20210540
- VernacularTitle:温经汤加味对EM肾虚血瘀型大鼠JAK2/STAT3信号通路及其下游因子的影响
- Author:
Rui-ying SUN
1
;
Yi-fan CUI
2
;
Juan CAO
2
;
Rui JIAO
2
Author Information
1. Second Clinical College，Shanxi University of Chinese Medicine，Taiyuan 030000，China
2. Fourth Clinical College，School of Basic Medicine，School of Nursing，Shanxi University of Chinese Medicine，Jinzhong 030619，China
- Publication Type:Research Article
- Keywords:
modified Wenjingtang;
endometriosis;
tyrosine kinase 2（JAK2）/transcription factor 3（STAT3） signaling pathway;
vascular endothelial growth factor （VEGF）;
tumor necrosis factor-α （TNF-α）;
thrombospondin-1 （TSP-1）
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2021;27(5):41-51
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the therapeutic effect and mechanism of modified Wenjingtang on endometriosis （EM） rats with kidney deficiency and blood stasis. Method:The 10 from 105 SPF female healthy SD rats were randomly selected as the blank group. The rest constructed the rat model of kidney deficiency and blood stasis by compound factorial method. After the model was successfully established， 10 rats were randomly selected as the sham operation group， with only laparotomy and no intima suture， and the remaining rats were established with EM kidney deficiency and blood stasis type by autologous intimal transplantation. Fifty rats which were randomly selected from 56 successful rats were treated with the modified Wenjingtang （5，10，20 g·kg-1） and danazol group（63 mg·kg-1）， 1 time daily ， for 4 weeks. The endometrial tissues of each group were stained with hematoxylin eosin （HE） to observe the histopathology. The levels of inflammatory factors interleukin-10 （IL-10） and interleukin-17 （IL-17） in serum supernatant were detected by enzyme linked immunosorbent assay （ELISA）. Measuring the length（D1），width （D2） and height （D3） of the heterotopic foci in each group before and after treatment. Then calculating the volume of them. The expression of tyrosine kinase 2（JAK2），transcription factor 3 （STAT3），phosphorylation transcription factor 3 （p-STAT3）， vascular endothelial growth factor （VEGF）， tumor necrosis factor-α （TNF-α） and thrombospondin-1 （TSP-1） were detected by immunohistochemistry （IHC）. The expression of VEGF，TNF-α and TSP-1 was detected by Western blot. Result:Microscopic pathological observation showed that the endometrial glandular cells of the blank group were arranged in order， and the glandular and stromal cells grew well， compared with the blank group， the endometrial structure of the model group was complete， showing a cavity like or annular closed structure， with cyst formation， and the epithelium was cubic or columnar epithelium， most of the epithelial cells had secretion， the stroma was dense， and the matrix showed a little fibrosis There were a few glands and inflammatory cell infiltration. Compared with the blank group， the content of IL-10 in serum of model group was significantly decreased （P<0.01）， and the content of IL-17 was significantly increased （P<0.01）， the protein expression of JAK2， STAT3，p-STAT3， VEGF， TNF-α in endometrial tissue of model group was significantly increased （P<0.05）， and the expression of TSP-1 protein was significantly decreased （P<0.05）. Compared with the model group， the serum IL-10 content of rats in modified Wenjingtang treatment group increased significantly （P<0.01）， the IL-17 content decreased significantly （P<0.01）， and the volume of ectopic foci decreased significantly （P<0.01）. While the level of JAK2，STAT3，p-STAT3，TNF-α，VEGF protein in intimal tissue of modified Wenjingtang high and middle dose group decreased significantly （P<0.05） and the level of TSP-1 protein increased significantly （P<0.05）. Conclusion:Modified Wenjingtang can inhibit the invasion of ectopic foci in EM rats with kidney deficiency and blood stasis， the mechanism may be related to the intervention of immune barrier and block angiogenesis function mediated by JAK2/STAT3 signaling pathway activation.
